top of page
Telomera is co-funded by the European union

Development of a protocol for the prevention of the aging process

Objective and results of the project: The goal of the project is to create an innovative personalized medical service for slowing down the aging process and improving health. During the project, a clinical study will be conducted, during which the aim will be to combine genetic, epigenetic and blood laboratory tests in order to assess the biological age of people, and to create sets of food supplements that slow down the aging process and to study the effect of sets of food supplements on the aging process of people. The expected result of the project is a developed protocol for the prevention of the aging process, which will allow improving people's health and slowing down the aging process.

The project is implemented under the economic transformation and competitiveness development program progress instrument No. 05-001-01-05-07.

The project is financed by the European Regional Development Fund.

Project budget 294806,4 €, The amount of funding allocated by the EU Fund 170.478,24 €.

Project implementation period 09/2023 – 12/2024.

MB Telomerai is a company that develops and provides innovative health care services, which specializes in the field of health promotion and longevity. During the project, the company's researchers will create a service for the longevity segment, which includes innovative genetic and epigenetic research, extensive evaluation of health indicators, consultations on lifestyle and nutrition issues, and the rational use of food supplements important for longevity. The created service will be based on science - during the project, it is planned to carry out a biomedical study, during which the influence of food supplements on people's well-being, epigenetic and other indicators will be studied. In the future, the company plans to expand its range of wellness services, popularize a healthy lifestyle, and develop science-based wellness services.

Contacts: Director Dovydas Čalnaris, e-mail:, phone: +370 639 88229.

More information:

bottom of page